LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 25

Search options

  1. Article: Phosphorylation of the AMPAR-TARP Complex in Synaptic Plasticity.

    Park, Joongkyu

    Proteomes

    2018  Volume 6, Issue 4

    Abstract: Synaptic plasticity has been considered a key mechanism underlying many brain functions including learning, memory, and drug addiction. An increase or decrease in synaptic activity of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor ( ... ...

    Abstract Synaptic plasticity has been considered a key mechanism underlying many brain functions including learning, memory, and drug addiction. An increase or decrease in synaptic activity of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) complex mediates the phenomena as shown in the cellular models of synaptic plasticity, long-term potentiation (LTP), and depression (LTD). In particular, protein phosphorylation shares the spotlight in expressing the synaptic plasticity. This review summarizes the studies on phosphorylation of the AMPAR pore-forming subunits and auxiliary proteins including transmembrane AMPA receptor regulatory proteins (TARPs) and discusses its role in synaptic plasticity.
    Language English
    Publishing date 2018-10-08
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2720995-7
    ISSN 2227-7382
    ISSN 2227-7382
    DOI 10.3390/proteomes6040040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: NMDA receptor-targeted enrichment of CaMKIIα improves fear memory.

    Chifor, Anthony / Choi, Jeongyoon / Park, Joongkyu

    iScience

    2022  Volume 25, Issue 8, Page(s) 104864

    Abstract: The establishment of effective molecular interventions to improve memory and alleviate memory deficits in disease remains a long-standing challenge despite growing molecular understanding of synaptic plasticity and memory formation. Capitalizing on the ... ...

    Abstract The establishment of effective molecular interventions to improve memory and alleviate memory deficits in disease remains a long-standing challenge despite growing molecular understanding of synaptic plasticity and memory formation. Capitalizing on the fact that long-term potentiation (LTP) requires N-methyl-D-aspartate receptors (NMDARs) and Ca
    Language English
    Publishing date 2022-08-02
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2022.104864
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Chemogenetic regulation of the TARP-lipid interaction mimics LTP and reversibly modifies behavior.

    Park, Joongkyu / Berthoux, Coralie / Hoyos-Ramirez, Erika / Shan, Lili / Morimoto-Tomita, Megumi / Wang, Yixiang / Castillo, Pablo E / Tomita, Susumu

    Cell reports

    2023  Volume 42, Issue 8, Page(s) 112826

    Abstract: Long-term potentiation (LTP), a well-characterized form of synaptic plasticity, is believed to underlie memory formation. Hebbian, postsynaptically expressed LTP requires TARPγ-8 phosphorylation for synaptic insertion of AMPA receptors (AMPARs). However, ...

    Abstract Long-term potentiation (LTP), a well-characterized form of synaptic plasticity, is believed to underlie memory formation. Hebbian, postsynaptically expressed LTP requires TARPγ-8 phosphorylation for synaptic insertion of AMPA receptors (AMPARs). However, it is unknown whether TARP-mediated AMPAR insertion alone is sufficient to modify behavior. Here, we report the development of a chemogenetic tool, ExSYTE (Excitatory SYnaptic Transmission modulator by Engineered TARPγ-8), to mimic the cytoplasmic interaction of TARP with the plasma membrane in a doxycycline-dependent manner. We use this tool to examine the specific role of synaptic AMPAR potentiation in amygdala neurons that are activated by fear conditioning. Selective expression of active ExSYTE in these neurons potentiates AMPAR-mediated synaptic transmission in a doxycycline-dependent manner, occludes synaptically induced LTP, and mimics freezing triggered by cued fear conditioning. Thus, chemogenetic controlling of the TARP-membrane interaction is sufficient for LTP-like synaptic AMPAR insertion, which mimics fear conditioning.
    MeSH term(s) Long-Term Potentiation/physiology ; Doxycycline/pharmacology ; Synapses/metabolism ; Synaptic Transmission ; Lipids
    Chemical Substances TARP ; Doxycycline (N12000U13O) ; Lipids
    Language English
    Publishing date 2023-07-19
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2023.112826
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The Troyer syndrome protein spartin mediates selective autophagy of lipid droplets.

    Chung, Jeeyun / Park, Joongkyu / Lai, Zon Weng / Lambert, Talley J / Richards, Ruth C / Zhang, Jiuchun / Walther, Tobias C / Farese, Robert V

    Nature cell biology

    2023  Volume 25, Issue 8, Page(s) 1101–1110

    Abstract: Lipid droplets (LDs) are crucial organelles for energy storage and lipid homeostasis. Autophagy of LDs is an important pathway for their catabolism, but the molecular mechanisms mediating LD degradation by selective autophagy (lipophagy) are unknown. ... ...

    Abstract Lipid droplets (LDs) are crucial organelles for energy storage and lipid homeostasis. Autophagy of LDs is an important pathway for their catabolism, but the molecular mechanisms mediating LD degradation by selective autophagy (lipophagy) are unknown. Here we identify spartin as a receptor localizing to LDs and interacting with core autophagy machinery, and we show that spartin is required to deliver LDs to lysosomes for triglyceride mobilization. Mutations in SPART (encoding spartin) lead to Troyer syndrome, a form of complex hereditary spastic paraplegia
    MeSH term(s) Mice ; Humans ; Animals ; Spastic Paraplegia, Hereditary/genetics ; Spastic Paraplegia, Hereditary/metabolism ; Lipid Droplets/metabolism ; Cell Cycle Proteins/metabolism ; Carrier Proteins/metabolism ; Autophagy ; Triglycerides/metabolism ; Lipid Metabolism/physiology
    Chemical Substances Cell Cycle Proteins ; Carrier Proteins ; Triglycerides
    Language English
    Publishing date 2023-07-13
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 1474722-4
    ISSN 1476-4679 ; 1465-7392
    ISSN (online) 1476-4679
    ISSN 1465-7392
    DOI 10.1038/s41556-023-01178-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Chemogenetic regulation of the TARP-lipid interaction mimics LTP and reversibly modifies behavior

    Joongkyu Park / Coralie Berthoux / Erika Hoyos-Ramirez / Lili Shan / Megumi Morimoto-Tomita / Yixiang Wang / Pablo E. Castillo / Susumu Tomita

    Cell Reports, Vol 42, Iss 8, Pp 112826- (2023)

    2023  

    Abstract: Summary: Long-term potentiation (LTP), a well-characterized form of synaptic plasticity, is believed to underlie memory formation. Hebbian, postsynaptically expressed LTP requires TARPγ-8 phosphorylation for synaptic insertion of AMPA receptors (AMPARs). ...

    Abstract Summary: Long-term potentiation (LTP), a well-characterized form of synaptic plasticity, is believed to underlie memory formation. Hebbian, postsynaptically expressed LTP requires TARPγ-8 phosphorylation for synaptic insertion of AMPA receptors (AMPARs). However, it is unknown whether TARP-mediated AMPAR insertion alone is sufficient to modify behavior. Here, we report the development of a chemogenetic tool, ExSYTE (Excitatory SYnaptic Transmission modulator by Engineered TARPγ-8), to mimic the cytoplasmic interaction of TARP with the plasma membrane in a doxycycline-dependent manner. We use this tool to examine the specific role of synaptic AMPAR potentiation in amygdala neurons that are activated by fear conditioning. Selective expression of active ExSYTE in these neurons potentiates AMPAR-mediated synaptic transmission in a doxycycline-dependent manner, occludes synaptically induced LTP, and mimics freezing triggered by cued fear conditioning. Thus, chemogenetic controlling of the TARP-membrane interaction is sufficient for LTP-like synaptic AMPAR insertion, which mimics fear conditioning.
    Keywords CP: Neuroscience ; CP: Cell biology ; Biology (General) ; QH301-705.5
    Subject code 571
    Language English
    Publishing date 2023-08-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation.

    Lee, Ye Hyung / Im, Eunju / Hyun, Minju / Park, Joongkyu / Chung, Kwang Chul

    The Journal of biological chemistry

    2021  Volume 296, Page(s) 100245

    Abstract: Down syndrome (DS) is mainly caused by an extra copy of chromosome 21 (trisomy 21), and patients display a variety of developmental symptoms, including characteristic facial features, physical growth delay, intellectual disability, and neurodegeneration ( ...

    Abstract Down syndrome (DS) is mainly caused by an extra copy of chromosome 21 (trisomy 21), and patients display a variety of developmental symptoms, including characteristic facial features, physical growth delay, intellectual disability, and neurodegeneration (i.e., Alzheimer's disease; AD). One of the pathological hallmarks of AD is insoluble deposits of neurofibrillary tangles (NFTs) that consist of hyperphosphorylated tau. The human DYRK1A gene is mapped to chromosome 21, and the protein is associated with the formation of inclusion bodies in AD. For example, DYRK1A directly phosphorylates multiple serine and threonine residues of tau, including Thr212. However, the mechanism underpinning DYRK1A involvement in Trisomy 21-related pathological tau aggregation remains unknown. Here, we explored a novel regulatory mechanism of DYRK1A and subsequent tau pathology through a phosphatase. Using LC-MS/MS technology, we analyzed multiple DYRK1A-binding proteins, including PPM1B, a member of the PP2C family of Ser/Thr protein phosphatases, in HEK293 cells. We found that PPM1B dephosphorylates DYRK1A at Ser258, contributing to the inhibition of DYRK1A activity. Moreover, PPM1B-mediated dephosphorylation of DYRK1A reduced tau phosphorylation at Thr212, leading to inhibition of toxic tau oligomerization and aggregation. In conclusion, our study demonstrates that DYRK1A autophosphorylates Ser258, the dephosphorylation target of PPM1B, and PPM1B negatively regulates DYRK1A activity. This finding also suggests that PPM1B reduces the toxic formation of phospho-tau protein via DYRK1A modulation, possibly providing a novel cellular protective mechanism to regulate toxic tau-mediated neuropathology in AD of DS.
    MeSH term(s) Alzheimer Disease/complications ; Alzheimer Disease/genetics ; Alzheimer Disease/pathology ; Carrier Proteins/genetics ; Chromatography, Liquid ; Down Syndrome/complications ; Down Syndrome/genetics ; Down Syndrome/pathology ; HEK293 Cells ; Humans ; Nerve Degeneration ; Neurofibrillary Tangles/genetics ; Neurofibrillary Tangles/pathology ; Phosphoprotein Phosphatases/genetics ; Phosphorylation/genetics ; Protein Aggregation, Pathological/genetics ; Protein Phosphatase 2C/genetics ; Protein Serine-Threonine Kinases/genetics ; Protein-Tyrosine Kinases/genetics ; Tandem Mass Spectrometry ; tau Proteins/genetics ; Dyrk Kinases
    Chemical Substances Carrier Proteins ; tau Proteins ; Protein-Tyrosine Kinases (EC 2.7.10.1) ; Protein Serine-Threonine Kinases (EC 2.7.11.1) ; PPM1B protein, human (EC 3.1.3.16) ; Phosphoprotein Phosphatases (EC 3.1.3.16) ; Protein Phosphatase 2C (EC 3.1.3.16)
    Language English
    Publishing date 2021-01-08
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.RA120.015574
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: New Perspectives of Dyrk1A Role in Neurogenesis and Neuropathologic Features of Down Syndrome.

    Park, Joongkyu / Chung, Kwang Chul

    Experimental neurobiology

    2013  Volume 22, Issue 4, Page(s) 244–248

    Abstract: Down syndrome (DS) is one of the most common genetic disorders accompanying with mental retardation, cognitive impairment, and deficits in learning and memory. The brains with DS also display many neuropathological features including alteration in ... ...

    Abstract Down syndrome (DS) is one of the most common genetic disorders accompanying with mental retardation, cognitive impairment, and deficits in learning and memory. The brains with DS also display many neuropathological features including alteration in neurogenesis and synaptogenesis and early onset of Alzheimer's disease (AD)-like symptoms. Triplication of all or a part of human chromosome 21, especially the 21q22.1~21q22.3 region called 'Down syndrome critical region (DSCR)', has been considered as the main cause of DS. One gene product of DSCR, dual-specificity tyrosine-phosphorylation-regulated kinase 1A (Dyrk1A), has been highlighted as a key contributor to the neural consequences of DS. This minireview summarizes accumulating recent reports about Dyrk1A involvement in the neuritogenesis, synaptogenesis, and AD-like neurofibrillary tangle formation, which is mainly focusing on Dyrk1A-mediated regulation of cytoskeletal proteins, such as tubulin, actin, and microtubule-associated protein tau. Understanding the molecular mechanisms of these phenomena may provide us a rational for new preventive and therapeutic treatment of DS.
    Language English
    Publishing date 2013-12-31
    Publishing country Korea (South)
    Document type Journal Article ; Review
    ZDB-ID 2639017-6
    ISSN 2093-8144 ; 1226-2560
    ISSN (online) 2093-8144
    ISSN 1226-2560
    DOI 10.5607/en.2013.22.4.244
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: TMEM163 Regulates ATP-Gated P2X Receptor and Behavior.

    Salm, Elizabeth J / Dunn, Patrick J / Shan, Lili / Yamasaki, Miwako / Malewicz, Nathalie M / Miyazaki, Taisuke / Park, Joongkyu / Sumioka, Akio / Hamer, R Richard L / He, Wei-Wu / Morimoto-Tomita, Megumi / LaMotte, Robert H / Tomita, Susumu

    Cell reports

    2020  Volume 31, Issue 9, Page(s) 107704

    Abstract: Fast purinergic signaling is mediated by ATP and ATP-gated ionotropic P2X receptors (P2XRs), and it is implicated in pain-related behaviors. The properties exhibited by P2XRs vary between those expressed in heterologous cells and in vivo. Several ... ...

    Abstract Fast purinergic signaling is mediated by ATP and ATP-gated ionotropic P2X receptors (P2XRs), and it is implicated in pain-related behaviors. The properties exhibited by P2XRs vary between those expressed in heterologous cells and in vivo. Several modulators of ligand-gated ion channels have recently been identified, suggesting that there are P2XR functional modulators in vivo. Here, we establish a genome-wide open reading frame (ORF) collection and perform functional screening to identify modulators of P2XR activity. We identify TMEM163, which specifically modulates the channel properties and pharmacology of P2XRs. We also find that TMEM163 is required for full function of the neuronal P2XR and a pain-related ATP-evoked behavior. These results establish TMEM163 as a critical modulator of P2XRs in vivo and a potential target for the discovery of drugs for treating pain.
    MeSH term(s) Adenosine Triphosphate/pharmacology ; Animals ; Behavior, Animal/drug effects ; Calcium/metabolism ; Evoked Potentials/drug effects ; Female ; Genome ; HEK293 Cells ; Humans ; Membrane Proteins/antagonists & inhibitors ; Membrane Proteins/genetics ; Membrane Proteins/metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Neurons/metabolism ; Open Reading Frames/genetics ; Pain/pathology ; RNA Interference ; RNA, Small Interfering/metabolism ; Receptors, Purinergic P2X/genetics ; Receptors, Purinergic P2X/metabolism ; Receptors, Purinergic P2X3/deficiency ; Receptors, Purinergic P2X3/genetics ; Receptors, Purinergic P2X3/metabolism
    Chemical Substances Membrane Proteins ; RNA, Small Interfering ; Receptors, Purinergic P2X ; Receptors, Purinergic P2X3 ; Tmem163 protein, mouse ; Adenosine Triphosphate (8L70Q75FXE) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2020-05-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2020.107704
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: TMEM163 Regulates ATP-Gated P2X Receptor and Behavior

    Elizabeth J. Salm / Patrick J. Dunn / Lili Shan / Miwako Yamasaki / Nathalie M. Malewicz / Taisuke Miyazaki / Joongkyu Park / Akio Sumioka / R. Richard L. Hamer / Wei-Wu He / Megumi Morimoto-Tomita / Robert H. LaMotte / Susumu Tomita

    Cell Reports, Vol 31, Iss 9, Pp - (2020)

    2020  

    Abstract: Summary: Fast purinergic signaling is mediated by ATP and ATP-gated ionotropic P2X receptors (P2XRs), and it is implicated in pain-related behaviors. The properties exhibited by P2XRs vary between those expressed in heterologous cells and in vivo. ... ...

    Abstract Summary: Fast purinergic signaling is mediated by ATP and ATP-gated ionotropic P2X receptors (P2XRs), and it is implicated in pain-related behaviors. The properties exhibited by P2XRs vary between those expressed in heterologous cells and in vivo. Several modulators of ligand-gated ion channels have recently been identified, suggesting that there are P2XR functional modulators in vivo. Here, we establish a genome-wide open reading frame (ORF) collection and perform functional screening to identify modulators of P2XR activity. We identify TMEM163, which specifically modulates the channel properties and pharmacology of P2XRs. We also find that TMEM163 is required for full function of the neuronal P2XR and a pain-related ATP-evoked behavior. These results establish TMEM163 as a critical modulator of P2XRs in vivo and a potential target for the discovery of drugs for treating pain.
    Keywords ion channel ; P2X receptor ; ATP ; modulator ; channel ; pharmacology ; Biology (General) ; QH301-705.5
    Subject code 572
    Language English
    Publishing date 2020-06-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Function and regulation of Dyrk1A: towards understanding Down syndrome.

    Park, Joongkyu / Song, Woo-Joo / Chung, Kwang Chul

    Cellular and molecular life sciences : CMLS

    2009  Volume 66, Issue 20, Page(s) 3235–3240

    Abstract: Down syndrome (DS) is associated with a variety of symptoms, such as incapacitating mental retardation and neurodegeneration (i.e., Alzheimer's disease), that prevent patients from leading fully independent lives. These phenotypes are a direct ... ...

    Abstract Down syndrome (DS) is associated with a variety of symptoms, such as incapacitating mental retardation and neurodegeneration (i.e., Alzheimer's disease), that prevent patients from leading fully independent lives. These phenotypes are a direct consequence of the overexpression of chromosome 21 genes, which are present in duplicate due to non-disjunction of chromosome 21. Accumulating data suggest that the chromosome 21 gene product, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (Dyrk1A), participates in the pathogenic mechanisms underlying the mental and other physical symptoms of DS. In this review, we summarize the evidence supporting a role for Dyrk1A in DS, especially DS pathogenesis. Recently, several natural and synthetic compounds have been identified as Dyrk1A inhibitors. Understanding the function and regulation of Dyrk1A may lead to the development of novel therapeutic agents aimed at treating DS.
    MeSH term(s) Animals ; Chromosomes, Human, Pair 21 ; Disease Models, Animal ; Down Syndrome/drug therapy ; Down Syndrome/genetics ; Gene Expression Regulation ; Humans ; Mice ; Protein Serine-Threonine Kinases/genetics ; Protein Serine-Threonine Kinases/physiology ; Protein-Tyrosine Kinases/genetics ; Protein-Tyrosine Kinases/physiology ; Dyrk Kinases
    Chemical Substances Protein-Tyrosine Kinases (EC 2.7.10.1) ; Protein Serine-Threonine Kinases (EC 2.7.11.1)
    Language English
    Publishing date 2009-08-14
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1358415-7
    ISSN 1420-9071 ; 1420-682X
    ISSN (online) 1420-9071
    ISSN 1420-682X
    DOI 10.1007/s00018-009-0123-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top